Question 1

What are the potential side effects of the AZD1222 vaccine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults clinical trial (NCT04516746). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this vaccine compare to other COVID-19 vaccines available?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults clinical trial (NCT04516746). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the participation process look like for me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults clinical trial (NCT04516746). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults clinical trial (NCT04516746). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any costs involved in participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults clinical trial (NCT04516746). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults clinical trial (NCT04516746). Contact the study team or your healthcare provider for specific answers.

What this study is about